Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients.
Acute kidney injury
Comorbidity
Extracorporeal membrane oxygenation
Invasive mechanical ventilation
SARS-CoV‑2
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
21
08
2020
accepted:
22
10
2020
pubmed:
11
11
2020
medline:
26
11
2020
entrez:
10
11
2020
Statut:
ppublish
Résumé
On February 25, 2020, the first 2 patients were tested positive for severe acute respiratory syndrome coronavirus‑2 (SARS-CoV-2) in Tyrol, Austria. Rapid measures were taken to ensure adequate intensive care unit (ICU) preparedness for a surge of critically ill coronavirus disease-2019 (COVID-19) patients. This cohort study included all COVID-19 patients admitted to an ICU with confirmed or strongly suspected COVID-19 in the State of Tyrol, Austria. Patients were recorded in the Tyrolean COVID-19 intensive care registry. Date of final follow-up was July 17, 2020. A total of 106 critically ill patients with COVID-19 were admitted to 1 of 13 ICUs in Tyrol from March 9 to July 17, 2020. Median age was 64 years (interquartile range, IQR 54-74 years) and the majority of patients were male (76 patients, 71.7%). Median simplified acute physiology score III (SAPS III) was 56 points (IQR 49-64 points). The median duration from appearance of first symptoms to ICU admission was 8 days (IQR 5-11 days). Invasive mechanical ventilation was required in 72 patients (67.9%) and 6 patients (5.6%) required extracorporeal membrane oxygenation treatment. Renal replacement therapy was necessary in 21 patients (19.8%). Median ICU length of stay (LOS) was 18 days (IQR 5-31 days), median hospital LOS was 27 days (IQR 13-49 days). The ICU mortality was 21.7% (23 patients), hospital mortality was 22.6%. There was no significant difference in ICU mortality in patients receiving invasive mechanical ventilation and in those not receiving it (18.1% vs. 29.4%, p = 0.284). As of July 17th, 2020, two patients are still hospitalized, one in an ICU, one on a general ward. Critically ill COVID-19 patients in Tyrol showed high severity of disease often requiring complex treatment with increased lengths of ICU and hospital stay. Nevertheless, the mortality was found to be remarkably low, which may be attributed to our adaptive surge response providing sufficient ICU resources.
Identifiants
pubmed: 33170333
doi: 10.1007/s00508-020-01764-0
pii: 10.1007/s00508-020-01764-0
pmc: PMC7653454
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-663Références
JAMA. 2009 Nov 4;302(17):1888-95
pubmed: 19822628
Crit Care. 2020 Jul 9;24(1):406
pubmed: 32646467
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
ASAIO J. 2020 May;66(5):472-474
pubmed: 32243267
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Crit Care. 2020 Jun 18;24(1):356
pubmed: 32552872
Crit Care. 2020 Apr 22;24(1):165
pubmed: 32321562
Intensive Care Med. 2020 Jul;46(7):1303-1325
pubmed: 32514598
Intensive Care Med. 2020 Apr;46(4):654-672
pubmed: 31820034
Intensive Care Med. 2020 Jul;46(7):1339-1348
pubmed: 32533197
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822
pubmed: 32798472
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Lancet Respir Med. 2020 Sep;8(9):853-862
pubmed: 32735842
Intensive Care Med. 2020 Aug;46(8):1634-1636
pubmed: 32451583
Crit Care. 2020 Jun 5;24(1):293
pubmed: 32503593
Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278
pubmed: 32519944
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Wien Klin Wochenschr. 2020 Nov;132(21-22):671-676
pubmed: 32621065
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Diabetologia. 2020 Aug;63(8):1500-1515
pubmed: 32472191
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
N Engl J Med. 2020 Jul 17;:
pubmed: 32678530
JAMA. 2020 Jun 2;323(21):2195-2198
pubmed: 32329797